Expanded Access Study of Alectinib for Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC) After Disease Progression on or Intolerance to Prior ALK Tyrosine Kinase Inhibitor Therapy
Public ClinicalTrials.gov record NCT02271139. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open Label, Multicenter, Single-Arm, Expanded Access Study of Alectinib for Patients With ALK-Rearranged Non-Small Cell Lung Cancer After Disease Progression on or Intolerance to Prior ALK Tyrosine Kinase Inhibitor Therapy
Study identification
- NCT ID
- NCT02271139
- Recruitment status
- No Longer Available
- Study type
- Expanded access
- Phase
- Not listed
- Lead sponsor
- Genentech, Inc.
- Industry
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
- Alectinib Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Mar 8, 2017
United States locations
- U.S. sites
- 45
- U.S. states
- 22
- U.S. cities
- 38
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama | Bimingham | Alabama | 35226 | — |
| Southern Cancer Center | Daphne | Alabama | 36526 | — |
| Southern Cancer Center | Mobile | Alabama | 36607 | — |
| Southern Cancer Center - Mobile | Mobile | Alabama | 36608 | — |
| Southern Cancer Center, PC | Mobile | Alabama | 36608 | — |
| Lalita Pandit Inc. | Fountain Valley | California | 92708 | — |
| University of California San Diego Medical Center; Moores Cancer Center | La Jolla | California | 92037 | — |
| Loma Linda Cancer Center | Loma Linda | California | 92354 | — |
| LAC USC Medical Center | Los Angeles | California | 90033 | — |
| University of Southern California | Los Angeles | California | 90033 | — |
| University of California Irvine Medical Center | Orange | California | 92868 | — |
| St. Joseph Heritage Healthcare | Sebastopol | California | 95472 | — |
| Innovative Clinical Research Institute | Whittier | California | 90603 | — |
| University Cancer & Blood Center, LLC | Athens | Georgia | 30607 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| University of Chicago Hospital | Chicago | Illinois | 60637 | — |
| Loyola University Med Center | Maywood | Illinois | 60153 | — |
| Investigative Clin Rsch of IN | Indianapolis | Indiana | 46260 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Dana Farber Partners Can Ctr | Boston | Massachusetts | 02115-6084 | — |
| Beth Israel Deaconess Med Ctr; Hem/Onc | Boston | Massachusetts | 02215 | — |
| Barbara Ann Karmanos Cancer Institute | Detroit | Michigan | 48201 | — |
| Karmanos Cancer Institute - Farmington Hills/Weisberg Cancer Treatment Center | Farmington Hills | Michigan | 48334 | — |
| Henry Ford Health System | West Bloomfield | Michigan | 48322 | — |
| University of Minnesota | Minneapolis | Minnesota | 55455 | — |
| Comprehensive Cancer Care, P.C. | St Louis | Missouri | 63141 | — |
| Billings Clinic Cancer Center; Billings Cancer Research | Billings | Montana | 59101 | — |
| San Juan Oncology Associates | Farmington | New Mexico | 87401 | — |
| Columbia University Medical Center; Clinical Research Management Office | New York | New York | 10032 | — |
| W.G. Bill Hefner VA Medical Center | Salisbury | North Carolina | — | — |
| Mark H. Zangmeister Center | Columbus | Ohio | 43219 | — |
| Tulsa Cancer Institute | Tulsa | Oklahoma | 74146 | — |
| Oregon Health & Science Uni | Portland | Oregon | 97239 | — |
| Forbes Hospital | Monroeville | Pennsylvania | 15146 | — |
| Allegheny Valley Hospital | Natrona Heights | Pennsylvania | 15065 | — |
| Cancer Treatment Centers of America - Eastern Regional Medical Center | Philadelphia | Pennsylvania | 19124 | — |
| Allegheny Cancer Center | Pittsburgh | Pennsylvania | 15212 | — |
| West Penn Cancer Institute | Pittsburgh | Pennsylvania | 15224 | — |
| Medical University of South Carolina; Hollings Cancer Center | Charleston | South Carolina | 29425 | — |
| UT Southwestern Medical Center | Dallas | Texas | 75390-8813 | — |
| Virginia Cancer Specialists, PC | Fairfax | Virginia | 22031 | — |
| University of Washington Seattle Cancer Care Alliance | Seattle | Washington | 98195 | — |
| Northwest Medical Specialties | Tacoma | Washington | 98405 | — |
| University of Wisconsin; Oncology | Madison | Wisconsin | 53792 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02271139, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 8, 2017 · Synced Jun 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02271139 live on ClinicalTrials.gov.